Shionogi Of Japan Expects Peramivir Approval In January For Flu
This article was originally published in PharmAsia News
Executive Summary
Japan's Shionogi expects to begin selling peramivir, an intravenous flu drug, in Japan as early as January, when the company hopes to receive health ministry approval